RGLS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.35%

Insider Buying (Last 12 Months): $82,566.60

Insider Selling (Last 12 Months): $282,237.48

Regulus Therapeutics Insider Trading History Chart

Regulus Therapeutics Share Price & Price History

^$7.98

▲ +4.61 (136.80%)

As of 04/30/2025 05:00 PM ET

Days: 30 | 90 | 365

Regulus Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/30/2025	David Baltimore	Director	Buy	19,610	$1.06	$20,786.60	22,169
1/30/2025	Joseph P. Hagan	CEO	Buy	50,000	$1.09	$54,500.00	260,808
1/13/2025	Christopher Ray Aker	VP	Sell	38,547	$1.26	$48,569.22	54,634
1/13/2025	Crispina Calsada	CFO	Sell	38,716	$1.26	$48,782.16	50,566
1/13/2025	Joseph P. Hagan	CEO	Sell	115,290	$1.26	$145,265.40	222,572
1/13/2025	Preston Klassen	Insider	Sell	31,445	$1.26	$39,620.70	36,055
7/25/2024	Kathryn J Collier	Director	Buy	4,000	$1.82	$7,280.00	6,740
1/18/2024	Crispina Calsada	CFO	Sell	5,468	$1.19	$6,506.92	5,782
1/18/2024	Joseph P. Hagan	CEO	Sell	14,580	$1.19	$17,350.20	57,112

SEC Filings (Institutional Ownership Changes) for Regulus Therapeutics (NASDAQ:RGLS)

92.38% of Regulus Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regulus Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2025	Tyche Wealth Partners LLC	121,589	$0.21M	0.0%	+14.6%	0.184%
4/23/2025	Oppenheimer & Co. Inc.	55,000	$96K	0.0%	N/A	0.083%
2/17/2025	Velan Capital Investment Management LP	70,000	$0.11M	0.1%	N/A	0.107%
2/17/2025	Octagon Capital Advisors LP	4,848,802	$7.66M	1.3%	+13.7%	7.403%
2/17/2025	Millennium Management LLC	2,192,158	$3.46M	0.0%	+69.7%	3.347%
2/17/2025	DAFNA Capital Management LLC	875,200	$1.38M	0.4%	-2.2%	1.336%
2/14/2025	RA Capital Management L.P.	336,843	$0.53M	0.0%	-56.1%	0.514%
2/14/2025	Northern Trust Corp	457,233	$0.72M	0.0%	-8.1%	0.698%
2/14/2025	Price T Rowe Associates Inc. MD	29,597	$47K	0.0%	-98.6%	0.045%
2/13/2025	PEAK6 LLC	60,000	$95K	0.0%	N/A	0.092%
2/13/2025	Barclays PLC	96,247	$0.15M	0.0%	+13.9%	0.147%
2/13/2025	Renaissance Technologies LLC	117,100	$0.19M	0.0%	+20.5%	0.179%
2/12/2025	JPMorgan Chase & Co.	190,457	$0.30M	0.0%	+141.2%	0.291%
2/6/2025	Victory Capital Management Inc.	389,886	$0.62M	0.0%	-2.3%	0.595%
1/30/2025	Rhumbline Advisers	59,531	$94K	0.0%	-20.1%	0.091%
12/26/2024	JPMorgan Chase & Co.	78,972	$0.12M	0.0%	+193.4%	0.121%
11/19/2024	Barclays PLC	84,477	$0.13M	0.0%	+285.2%	0.129%
11/16/2024	Geode Capital Management LLC	1,280,567	$2.01M	0.0%	-4.0%	1.955%
11/15/2024	Barclays PLC	84,477	$0.13M	0.0%	+285.2%	0.129%
11/15/2024	Jane Street Group LLC	29,580	$46K	0.0%	N/A	0.045%
11/15/2024	State Street Corp	1,000,998	$1.57M	0.0%	+3.5%	1.528%
11/15/2024	RA Capital Management L.P.	766,834	$1.20M	0.0%	-87.7%	1.171%
11/15/2024	Point72 Asset Management L.P.	893,762	$1.40M	0.0%	N/A	1.365%
11/14/2024	NEA Management Company LLC	6,467,802	$10.15M	0.6%	N/A	9.875%
11/13/2024	FMR LLC	328,157	$0.52M	0.0%	-83.8%	0.501%
11/13/2024	The Manufacturers Life Insurance Company	129,700	$0.20M	0.0%	N/A	0.198%
11/5/2024	Victory Capital Management Inc.	398,866	$0.63M	0.0%	+10.4%	0.609%
10/25/2024	Tyche Wealth Partners LLC	106,089	$0.17M	0.0%	+920.6%	0.162%
10/11/2024	Creative Planning	16,466	$26K	0.0%	N/A	0.025%
10/3/2024	SG Americas Securities LLC	20,800	$33K	0.0%	N/A	0.032%
8/15/2024	CVI Holdings LLC	401,012	$0.72M	0.6%	-71.5%	0.613%
8/9/2024	Renaissance Technologies LLC	118,100	$0.21M	0.0%	+56.4%	0.180%
8/5/2024	Victory Capital Management Inc.	361,386	$0.65M	0.0%	-1.8%	0.552%
8/1/2024	Rhumbline Advisers	76,472	$0.14M	0.0%	N/A	0.117%
7/26/2024	Bank of New York Mellon Corp	197,193	$0.35M	0.0%	N/A	0.301%
5/29/2024	Opaleye Management Inc.	170,308	$0.49M	0.1%	N/A	0.260%
5/17/2024	RA Capital Management L.P.	6,250,000	$18M	0.2%	N/A	9.547%
5/15/2024	NEA Management Company LLC	6,467,802	$18.63M	1.1%	N/A	9.879%
5/10/2024	Vanguard Group Inc.	740,215	$2.13M	0.0%	+158.4%	1.131%
5/7/2024	CVI Holdings LLC	1,406,250	$4.05M	3.9%	N/A	2.148%
4/22/2024	Vivo Capital LLC	5,000,000	$14.40M	1.1%	N/A	7.638%
2/5/2024	Victory Capital Management Inc.	271,736	$0.35M	0.0%	+16.5%	1.344%
11/13/2023	FMR LLC	2,922,600	$4.03M	0.0%	+32.4%	14.454%
11/6/2023	Victory Capital Management Inc.	233,207	$0.32M	0.0%	+5.3%	1.197%
8/14/2023	Prelude Capital Management LLC	40,660	$60K	0.0%	N/A	0.209%
9/16/2022	Federated Hermes Inc.	2,904,826	$6.01M	0.0%	-90.0%	19.850%
8/16/2022	DAFNA Capital Management LLC	555,555	$1.15M	0.3%	-90.0%	3.797%
8/12/2022	Ikarian Capital LLC	105,341	$0.22M	0.0%	-91.8%	0.722%
8/1/2022	Victory Capital Management Inc.	221,506	$0.46M	0.0%	-90.1%	1.517%
7/19/2022	Commonwealth Equity Services LLC	22,000	$45K	0.0%	-83.2%	0.151%
2/14/2022	DAFNA Capital Management LLC	5,555,555	$1.75M	0.4%	N/A	6.382%
1/19/2022	Asymmetry Capital Management L.P.	2,731,044	$0.86M	0.5%	+94.9%	3.137%
11/15/2021	GSA Capital Partners LLP	64,708	$45K	0.0%	-68.6%	0.074%
11/4/2021	Asymmetry Capital Management L.P.	1,401,491	$0.97M	0.6%	-3.4%	1.610%
10/29/2021	Commonwealth Equity Services LLC	111,000	$76K	0.0%	+38.8%	0.128%
9/17/2021	Virtu Financial LLC	79,193	$64K	0.0%	N/A	0.091%
8/27/2021	Endurant Capital Management LP	2,607,674	$2.12M	0.6%	+9.7%	2.996%
8/16/2021	State Street Corp	176,494	$0.14M	0.0%	N/A	0.203%
8/13/2021	Geode Capital Management LLC	589,196	$0.48M	0.0%	+54.3%	0.786%
8/13/2021	Vanguard Group Inc.	3,095,237	$2.52M	0.0%	-3.9%	4.131%
8/12/2021	Lido Advisors LLC	57,500	$47K	0.0%	N/A	0.077%
8/11/2021	Commonwealth Equity Services LLC	80,000	$65K	0.0%	+300.0%	0.107%
8/10/2021	Strategic Wealth Advisors Group LLC	74,800	$61K	0.0%	N/A	0.100%
8/5/2021	GSA Capital Partners LLP	206,265	$0.17M	0.0%	N/A	0.275%
7/31/2021	Asymmetry Capital Management L.P.	1,450,777	$1.18M	0.8%	-26.9%	1.936%
7/15/2021	Focused Wealth Management Inc	200,000	$0.16M	0.0%	+100.0%	0.267%
5/19/2021	Squarepoint Ops LLC	159,804	$0.25M	0.0%	+1,477.7%	0.213%
5/17/2021	Endurant Capital Management LP	2,376,557	$3.71M	1.0%	N/A	3.172%
5/17/2021	Ikarian Capital LLC	1,245,989	$1.94M	0.1%	N/A	1.663%
5/17/2021	Atom Investors LP	337,228	$0.53M	0.1%	N/A	0.450%
5/17/2021	Goldman Sachs Group Inc.	18,049	$28K	0.0%	-68.0%	0.024%
5/12/2021	Northern Trust Corp	117,654	$0.18M	0.0%	+198.4%	0.157%
5/12/2021	Geode Capital Management LLC	381,892	$0.60M	0.0%	+493.5%	0.510%
5/11/2021	Acadian Asset Management LLC	465,678	$0.73M	0.0%	N/A	0.622%
5/11/2021	Asymmetry Capital Management L.P.	1,985,472	$3.10M	1.6%	N/A	2.650%
5/4/2021	Commonwealth Equity Services LLC	20,000	$31K	0.0%	N/A	0.027%
5/4/2021	Victory Capital Management Inc.	2,227,199	$3.47M	0.0%	+345.4%	2.976%
5/3/2021	Focused Wealth Management Inc	100,000	$0.16M	0.0%	N/A	0.134%

Data available starting January 2016

See Full Table

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $7.98

$7.70

$8.20

50 Day Range

MA: $1.84

$1.26

$7.98

52 Week Range

Now: $7.98

$0.83

$8.20

Volume

28,542,660 shs

Average Volume

834,881 shs

Market Capitalization

$528.62 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

Who are the company insiders with the largest holdings of Regulus Therapeutics?: Regulus Therapeutics' top insider investors include:
Joseph P Hagan (CEO)
Christopher Ray Aker (VP)
Crispina Calsada (CFO)
Preston Klassen (Insider)
David Baltimore (Director)
Kathryn J Collier (Director)
Learn More about top insider investors at Regulus Therapeutics.
Who are the major institutional investors of Regulus Therapeutics?: Regulus Therapeutics' top institutional investors include:
Tyche Wealth Partners LLC — 0.18%
Oppenheimer & Co. Inc. — 0.08%
Learn More about top institutional investors of Regulus Therapeutics stock.
Which institutional investors are buying Regulus Therapeutics stock?: Within the last quarter, RGLS stock was bought by institutional investors including:
Oppenheimer & Co. Inc.
Tyche Wealth Partners LLC
During the previous year, these company insiders have bought Regulus Therapeutics stock:
Joseph P Hagan (CEO)
Christopher Ray Aker (VP)
Crispina Calsada (CFO)
Learn More investors buying Regulus Therapeutics stock.